五味子引起的过敏性支气管肺霉菌病的临床特征

IF 4.6 2区 医学 Q2 ALLERGY
Tsuyoshi Oguma, Takashi Ishiguro, Katsuhiko Kamei, Jun Tanaka, Junko Suzuki, Akira Hebisawa, Yasushi Obase, Hiroshi Mukae, Takae Tanosaki, Shiho Furusho, Koji Kurokawa, Kentaro Watai, Hiroto Matsuse, Norihiro Harada, Ai Nakamura, Takuo Shibayama, Rie Baba, Kentaro Fukunaga, Hisako Matsumoto, Hisano Ohba, Susumu Sakamoto, Shinko Suzuki, Shintetsu Tanaka, Takahiro Yamada, Akira Yamasaki, Yuma Fukutomi, Yoshiki Shiraishi, Takahito Toyotome, Koichi Fukunaga, Terufumi Shimoda, Satoshi Konno, Masami Taniguchi, Katsuyoshi Tomomatsu, Naoki Okada, Koichiro Asano, Japan ABPM Research Program
{"title":"五味子引起的过敏性支气管肺霉菌病的临床特征","authors":"Tsuyoshi Oguma,&nbsp;Takashi Ishiguro,&nbsp;Katsuhiko Kamei,&nbsp;Jun Tanaka,&nbsp;Junko Suzuki,&nbsp;Akira Hebisawa,&nbsp;Yasushi Obase,&nbsp;Hiroshi Mukae,&nbsp;Takae Tanosaki,&nbsp;Shiho Furusho,&nbsp;Koji Kurokawa,&nbsp;Kentaro Watai,&nbsp;Hiroto Matsuse,&nbsp;Norihiro Harada,&nbsp;Ai Nakamura,&nbsp;Takuo Shibayama,&nbsp;Rie Baba,&nbsp;Kentaro Fukunaga,&nbsp;Hisako Matsumoto,&nbsp;Hisano Ohba,&nbsp;Susumu Sakamoto,&nbsp;Shinko Suzuki,&nbsp;Shintetsu Tanaka,&nbsp;Takahiro Yamada,&nbsp;Akira Yamasaki,&nbsp;Yuma Fukutomi,&nbsp;Yoshiki Shiraishi,&nbsp;Takahito Toyotome,&nbsp;Koichi Fukunaga,&nbsp;Terufumi Shimoda,&nbsp;Satoshi Konno,&nbsp;Masami Taniguchi,&nbsp;Katsuyoshi Tomomatsu,&nbsp;Naoki Okada,&nbsp;Koichiro Asano,&nbsp;Japan ABPM Research Program","doi":"10.1002/clt2.12327","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. <i>Schizophyllum commune</i>, a basidiomycete fungus, is one of the most common fungi that causes non-<i>Aspergillus</i> ABPM.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>Herein, we attempted to clarify the clinical characteristics of ABPM caused by <i>S. commune</i> (ABPM-Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Patients with ABPM-Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University. The definition of culture-positive ABPM-Sc/ABPA is as follows: (1) fulfills five or more of the 10 diagnostic criteria for ABPM proposed by Asano et al., and (2) positive culture of <i>S. commune/Aspergillus</i> spp. in sputum, bronchial lavage fluid, or mucus plugs in the bronchi.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Thirty patients with ABPM-Sc and 46 with ABPA were recruited. Patients with ABPM-Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA (<i>p</i> = 0.008–0.03). Central bronchiectasis was more common in ABPM-Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground-glass opacities or fibrotic/cystic changes, were less frequent in ABPM-Sc. <i>Aspergillus fumigatus</i>-specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM-Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM-Sc positive for <i>A. fumigatus</i>-specific IgE or ABPA.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Clinical characteristics of ABPM-Sc, especially those negative for <i>A. fumigatus</i>-specific IgE, differed from those of ABPA.</p>\n </section>\n </div>","PeriodicalId":10334,"journal":{"name":"Clinical and Translational Allergy","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clt2.12327","citationCount":"0","resultStr":"{\"title\":\"Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune\",\"authors\":\"Tsuyoshi Oguma,&nbsp;Takashi Ishiguro,&nbsp;Katsuhiko Kamei,&nbsp;Jun Tanaka,&nbsp;Junko Suzuki,&nbsp;Akira Hebisawa,&nbsp;Yasushi Obase,&nbsp;Hiroshi Mukae,&nbsp;Takae Tanosaki,&nbsp;Shiho Furusho,&nbsp;Koji Kurokawa,&nbsp;Kentaro Watai,&nbsp;Hiroto Matsuse,&nbsp;Norihiro Harada,&nbsp;Ai Nakamura,&nbsp;Takuo Shibayama,&nbsp;Rie Baba,&nbsp;Kentaro Fukunaga,&nbsp;Hisako Matsumoto,&nbsp;Hisano Ohba,&nbsp;Susumu Sakamoto,&nbsp;Shinko Suzuki,&nbsp;Shintetsu Tanaka,&nbsp;Takahiro Yamada,&nbsp;Akira Yamasaki,&nbsp;Yuma Fukutomi,&nbsp;Yoshiki Shiraishi,&nbsp;Takahito Toyotome,&nbsp;Koichi Fukunaga,&nbsp;Terufumi Shimoda,&nbsp;Satoshi Konno,&nbsp;Masami Taniguchi,&nbsp;Katsuyoshi Tomomatsu,&nbsp;Naoki Okada,&nbsp;Koichiro Asano,&nbsp;Japan ABPM Research Program\",\"doi\":\"10.1002/clt2.12327\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. <i>Schizophyllum commune</i>, a basidiomycete fungus, is one of the most common fungi that causes non-<i>Aspergillus</i> ABPM.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>Herein, we attempted to clarify the clinical characteristics of ABPM caused by <i>S. commune</i> (ABPM-Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Patients with ABPM-Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University. The definition of culture-positive ABPM-Sc/ABPA is as follows: (1) fulfills five or more of the 10 diagnostic criteria for ABPM proposed by Asano et al., and (2) positive culture of <i>S. commune/Aspergillus</i> spp. in sputum, bronchial lavage fluid, or mucus plugs in the bronchi.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Thirty patients with ABPM-Sc and 46 with ABPA were recruited. Patients with ABPM-Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA (<i>p</i> = 0.008–0.03). Central bronchiectasis was more common in ABPM-Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground-glass opacities or fibrotic/cystic changes, were less frequent in ABPM-Sc. <i>Aspergillus fumigatus</i>-specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM-Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM-Sc positive for <i>A. fumigatus</i>-specific IgE or ABPA.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Clinical characteristics of ABPM-Sc, especially those negative for <i>A. fumigatus</i>-specific IgE, differed from those of ABPA.</p>\\n </section>\\n </div>\",\"PeriodicalId\":10334,\"journal\":{\"name\":\"Clinical and Translational Allergy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2023-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clt2.12327\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Translational Allergy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/clt2.12327\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Allergy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clt2.12327","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

过敏性支气管肺霉菌病(ABPM)是一种由对环境真菌的 I 型和 III 型过敏引起的过敏性疾病。基生真菌 Schizophyllum commune 是引起非曲霉性支气管肺霉病的最常见真菌之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune

Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune

Background

Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most common fungi that causes non-Aspergillus ABPM.

Objective

Herein, we attempted to clarify the clinical characteristics of ABPM caused by S. commune (ABPM-Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA).

Methods

Patients with ABPM-Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University. The definition of culture-positive ABPM-Sc/ABPA is as follows: (1) fulfills five or more of the 10 diagnostic criteria for ABPM proposed by Asano et al., and (2) positive culture of S. commune/Aspergillus spp. in sputum, bronchial lavage fluid, or mucus plugs in the bronchi.

Results

Thirty patients with ABPM-Sc and 46 with ABPA were recruited. Patients with ABPM-Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA (p = 0.008–0.03). Central bronchiectasis was more common in ABPM-Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground-glass opacities or fibrotic/cystic changes, were less frequent in ABPM-Sc. Aspergillus fumigatus-specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM-Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM-Sc positive for A. fumigatus-specific IgE or ABPA.

Conclusions

Clinical characteristics of ABPM-Sc, especially those negative for A. fumigatus-specific IgE, differed from those of ABPA.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical and Translational Allergy
Clinical and Translational Allergy Immunology and Microbiology-Immunology
CiteScore
7.50
自引率
4.50%
发文量
117
审稿时长
12 weeks
期刊介绍: Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信